Galmed Pharmaceuticals (GLMD) Return on Capital Employed (2014 - 2020)

Galmed Pharmaceuticals' Return on Capital Employed history runs 7 years deep, the most recent figure standing at 34.39% for Q1 2020.

• In Q1 2020, Return on Capital Employed rose 2180.0% year-over-year to 34.39%; the TTM figure through Mar 2020 stood at 34.39% (up 2180.0% YoY), while the FY2024 annual figure was 11.23%, down 25.0% from the prior year.
• Return on Capital Employed was 34.39% for Q1 2020 at Galmed Pharmaceuticals, up from 28.41% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 199.69% in Q3 2017 to a low of 10.23% in Q3 2018.
• Historically, Return on Capital Employed has averaged 78.53% across 5 years, with a median of 76.82% in 2018.
• The sharpest annual moves came in 2017 and 2018: Return on Capital Employed jumped 10349 bps in 2017, then plunged 18946 bps in 2018.
• A 5-year view of Return on Capital Employed shows it stood at 127.28% in 2016, then slipped by 10 bps to 115.04% in 2017, then plunged by 91 bps to 10.61% in 2018, then soared by 168 bps to 28.41% in 2019, then grew by 21 bps to 34.39% in 2020.
• The last three Return on Capital Employed figures came in at 34.39% (Q1 2020), 28.41% (Q4 2019), and 16.12% (Q3 2019), per Business Quant data.